
11.33 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 6.25 Today|||52-Week Range 13.56 | +17.41% Year-to-Date |
Is Teva Pharmaceuticals a Safe Stock to Buy Now? Feb 21 / MotleyFool.com - Paid Partner Content | TEVA Stock Declines Despite Q4 Earnings and Sales Beat Feb 11 / Zacks.com - Paid Partner Content |
2 Stocks I'd Avoid at All Costs Feb 20 / MotleyFool.com - Paid Partner Content |
Previous close | 10.61 |
Today’s open | 10.64 |
Day’s range | 10.55 - 11.47 |
Volume | 15,957,137 |
Average volume (3 months) | 9,189,853 |
Market cap | $12.2B |
Earnings growth (last year) | -299.46% |
Earnings growth (this year) | +1.83% |
Earnings growth (next 5 years) | +4.03% |
Revenue growth (last year) | -0.90% |
P/E ratio | NM |
Price/Sales | 0.63 |
Price/Book | 1.22 |
Today’s change | Today’s % change | |
---|---|---|
BBIOBridgeBio Pharma Inc | +1.58 | +2.40% |
IMMBImmunotech Laborator... | 0.00 | 0.00% |
---- | ||
BGNEBeigene Ltd | +2.10 | +0.63% |
Next reporting date | May 13, 2021 |
EPS forecast (this quarter) | $0.59 |
Annual revenue (last year) | $16.8B |
Annual profit (last year) | -$4.0B |
Net profit margin | -23.95% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Petach Tikva, Hamerkaz |